Semaglutide Significantly Improves Chronic Kidney Disease

The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD.

Related Keywords

Germany ,Australia ,Madrid ,Spain ,Sydney ,New South Wales ,Stockholm ,Sweden ,Vlado Perkovic ,Alberto Ortiz ,Katheriner Tuttle ,Christoph Wanner ,European Renal Association ,Health Research Institute Of The Jim ,University Of Washington ,Division Of Nephrology ,Nephrology Division ,Kidney Research Institute ,Medscape Medical ,New England Journal ,Kidney Disease ,Improving Global Outcomes ,Medscape Medical News ,Hypertension Renal Unit ,Health Research Institute ,Related Kidney Disease ,